Contribution to the WHO Strategic Prepared-ness and Response Plan for addressing the Covid-19 pandemic


More than a year and a half after the emergence of SARS-CoV-2, the virus is still dominating the health, social and economic life worldwide. In the frame of its Covid-19 Strategic Preparedness and Response Plan (SPRP), WHO and partners are strengthening health systems of middle- and lower-income countries in their capacities to enable the rapid uptake and delivery of Covid-19 tools (vaccines, therapies and diagnostics) and to become more resilient to provide essential services at country level. 

Pays/région Thème Période Budget
Monde entier
Santé
Maladies infectieuses
Renforcement des systèmes de santé
01.11.2021 - 31.10.2022
CHF  10’000’000
Contexte

Despite the development of several effective and safe SARS-CoV-2 vaccines in record time, the spread of more infectious virus variants has resulted in increased infections and deaths. Insufficient access to vaccines and rapid diagnostic tests, as well as weak health system capacities to adequately roll them out, pose enormous challenges to low- and lower-middle income countries. In addition, an indirect adverse effect of the pandemic has been increasing deaths that have been documented worldwide, as health systems disruptions associated with the pandemic and response measures have impacted care for other health conditions.

Recognizing that the only way out of the pandemic is by bringing the spread of the virus under control in every country, Switzerland contributes to the global response through an additional credit of CHF 300 million for the Access to Covid-19 Tools Accelerator (ACT-A) (Federal Decree of 04.06.2021). As part of this investment, CHF 10 million are allotted to the WHO for supporting countries to facilitate the deployment of these tools by strengthening health systems. Through this contribution, Switzerland is supporting activities for pandemic preparedness and response that have been underfunded to date. Improved global health security is also in Switzerland's interests.

Objectifs

End the Covid-19 pandemic and build health systems’ resilience and readiness for the future

Groupes cibles

Ultimate beneficiaries: population in low-income countries and lower- and middle-income countries which are most impacted by Covid-19.

Direct beneficiaries: national and sub-national authorities, health systems and local community networks

Effets à moyen terme

·  Transmission of the virus is suppressed

·  Exposure to the virus is reduced

·  Misinformation and disinformation are countered

·  Vulnerable groups are protected through vaccination

·  Mortality and morbidity from all causes are reduced

-  Equitable access to new Covid-19 tools (vaccines, diagnostics and therapeutics) is accelerated 

 

 

Résultats

Principaux résultats attendus:  

·    Implementation of effective and evidence-based public health and social measures, infection prevention and control measures, and measures to protect high-risk groups.

·    Communities are enabled to adopt risk-reducing behaviors and to practice infection prevention and control.

·    Managing the infodemic, communicating with, engaging, and empowering communities, enriching the information eco-system online and offline through high-quality and accessible and appropriate health guidance.

·    Vaccine deployment readiness is ensured in all countries and for all populations, through Covid-19 vaccination campaigns, by engaging sufficient health workers, and by building vaccine acceptance and demand based on priority groups.

·    Core health systems are strengthened to maintain and meet the increasing demand for both Covid-19 care and other essential health services.

-    National planning of preparedness and response, along the 10 Pillars of the SPRP, are prepared, implemented and monitored. 


Principaux résultats antérieurs:  

Over the last 18 months, WHO provided support to national health systems in:

·    Accelerating innovative research on how to contain the spread of the virus. E.g. WHO has brought together more than 3000 researchers (40% of them from low-income or middle-income countries), from more than 1000 global institutions.

·    Leveraging global networks to adapt and update a comprehensive set of technical guidance for member states, from surveillance to clinical management, along with a readiness checklist and a disease commodity package for supply chain management. 

·    Training millions of health workers, in the field and online, and fixed broken supply chains to ensure that health workers have both the equipment and training to do their job safely and with an impact in reducing mortality and transmission.

·    Creating new tools and technologies to pioneer new ways of listening to and responding to communities. E.g. WHO compiled a compendium of 24 technologies that can be used in low-resource settings like ventilators with an extended battery life.

-     Counteracting infodemicwith different partners and modalities

 


Direction/office fédéral responsable DDC
Partenaire de projet Partenaire contractuel
Organisme des Nations Unies (ONU)
  • Organisation mondiale de la santé
  • WHO


Coordination avec d'autres projets et acteurs 1) Covid-19 Diagnostics Partnership; 2) Covid-19 Therapeutics Accelerator; 3) Supporting access to Covid-19 vaccines in humanitarian settings; 4) Additional Contribution to the Humanitarian Action for Children (HAC) window; 5) Additional Contribution to the IFRC Revised Emergency Appeal Covid-19 Pandemic 6) P4H
Budget Phase en cours Budget de la Suisse CHF    10’000’000 Budget suisse déjà attribué CHF    9’999’999